Filing Flows › Pro DEX (PDEX) › R&D spending
Pro DEX (PDEX) R&D spending by quarter
Pro DEX's R&D spending was $1.2M in Q1 FY27 (first quarter fiscal 2027), +19% from Q4 FY26. Over the last 7 quarters it ranged from $734K (Q2 FY26) to $1.2M (Q1 FY27).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $1.2M | +19% | +58% |
| Q4 FY26 | $1.0M | +23% | +12% |
| Q3 FY26 | $827K | +13% | -13% |
| Q2 FY26 | $734K | -4% | — |
| Q1 FY26 | $768K | -15% | — |
| Q4 FY25 | $905K | -4% | — |
| Q3 FY25 | $947K | — | — |
Q1 FY27 at a glance
Pro DEX, Q1 FY27: revenue $20.6M (+11% year over year), operating margin 17.1%, net earnings $3.0M, operating cash flow $6.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Pro DEX's R&D spending?
Pro DEX's R&D spending was $1.2M in Q1 FY27 (first quarter fiscal 2027), +19% from Q4 FY26.
How has Pro DEX's R&D spending changed?
Over the last 7 quarters it ranged from $734K (Q2 FY26) to $1.2M (Q1 FY27).